Default-Featured-Image-2

Published: October 23, 2020|Alicia Torborg

Migraine Minute News Update – October 23, 2020

On this week’s Migraine Minute News Update, Molly shares the status of two pipeline migraine treatments, Timolol and Qtrypta. She also recaps findings from a study The Headache and Migraine Policy Forum performed on how the pandemic is impacting migraine patients.

Learn more about each update:
https://rb.gy/msyywm
https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2771168
https://rb.gy/dxngfu

Recent Posts

The Relationship Between Migraine and Irritable Bowel Syndrome

The Importance of Asking About Adverse Childhood Experiences in People Living With Migraine

Everything You Wanted to Know About Sex and Migraine (But Were Afraid to Ask!)

Migraine and Spontaneous Coronary Artery Dissection (SCAD)

Ways To Get Involved In The Migraine Community

Recent Podcasts

S5:Ep5 – An Introduction to the Nerivio Device for the Treatment of Migraine

S5:Ep4 – Allodynia and Migraine

S5:Ep3 – Atogepant for the Preventive Treatment of Episodic Migraine

S5:Ep2 – The Relationship Between Patent Foramen Ovale and Migraine

S5:Ep1 – Migraine Stigma, Treatment, and Access: OVERCOME Study Findings

Newsletter Signup